Scotia Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.9M | Sell |
183,643
-4,561
| -2% | -$1.01M | 0.16% | 89 |
|
|
2025
Q4 | $43M | Buy |
188,204
+26,054
| +16% | +$5.94M | 0.17% | 85 |
|
|
2025
Q3 | $37.5M | Buy |
162,150
+22,624
| +16% | +$4.61M | 0.16% | 90 |
|
|
2025
Q2 | $25.9M | Buy |
139,526
+7,991
| +6% | +$1.49M | 0.12% | 103 |
|
|
2025
Q1 | $27.6M | Sell |
131,535
-3,389
| -3% | -$659K | 0.15% | 90 |
|
|
2024
Q4 | $24M | Sell |
134,924
-2,562
| -2% | -$471K | 0.13% | 99 |
|
|
2024
Q3 | $27.2M | Sell |
137,486
-17,963
| -12% | -$3.35M | 0.15% | 97 |
|
|
2024
Q2 | $26.7M | Sell |
155,449
-1,027
| -0.7% | -$170K | 0.16% | 92 |
|
|
2024
Q1 | $28.5M | Buy |
156,476
+1,036
| +0.7% | +$179K | 0.17% | 88 |
|
|
2023
Q4 | $24.1M | Buy |
155,440
+7,111
| +5% | +$1.04M | 0.16% | 94 |
|
|
2023
Q3 | $22.1M | Buy |
148,329
+745
| +0.5% | +$109K | 0.16% | 92 |
|
|
2023
Q2 | $19.9M | Sell |
147,584
-43,033
| -23% | -$6.31M | 0.14% | 102 |
|
|
2023
Q1 | $30.4M | Buy |
190,617
+2,016
| +1% | +$308K | 0.22% | 73 |
|
|
2022
Q4 | $30.5M | Buy |
188,601
+3,986
| +2% | +$611K | 0.23% | 74 |
|
|
2022
Q3 | $24.8M | Sell |
184,615
-13,897
| -7% | -$1.99M | 0.2% | 78 |
|
|
2022
Q2 | $30.4M | Buy |
198,512
+4,786
| +2% | +$731K | 0.23% | 71 |
|
|
2022
Q1 | $31.4M | Sell |
193,726
-42,485
| -18% | -$6.17M | 0.2% | 78 |
|
|
2021
Q4 | $32M | Buy |
236,211
+32,898
| +16% | +$3.89M | 0.21% | 80 |
|
|
2021
Q3 | $21.9M | Buy |
203,313
+13,379
| +7% | +$1.53M | 0.16% | 99 |
|
|
2021
Q2 | $21.4M | Sell |
189,934
-32,415
| -15% | -$3.65M | 0.16% | 94 |
|
|
2021
Q1 | $24.1M | Buy |
222,349
+9,964
| +5% | +$1.07M | 0.2% | 88 |
|
|
2020
Q4 | $22.8M | Buy |
212,385
+10,581
| +5% | +$1.02M | 0.21% | 87 |
|
|
2020
Q3 | $17.7M | Buy |
201,804
+43,764
| +28% | +$4.12M | 0.19% | 93 |
|
|
2020
Q2 | $15.5M | Buy |
158,040
+64,729
| +69% | +$5.7M | 0.22% | 79 |
|
|
2020
Q1 | $7.11M | Buy |
93,311
+19,891
| +27% | +$1.69M | 0.1% | 118 |
|
|
2019
Q4 | $6.5M | Sell |
73,420
-33,739
| -31% | -$2.8M | 0.07% | 150 |
|
|
2019
Q3 | $8.11M | Sell |
107,159
-27,062
| -20% | -$1.86M | 0.1% | 127 |
|
|
2019
Q2 | $9.76M | Buy |
134,221
+24,731
| +23% | +$1.94M | 0.12% | 110 |
|
|
2019
Q1 | $8.82M | Buy |
109,490
+8,975
| +9% | +$734K | 0.11% | 117 |
|
|
2018
Q4 | $9.27M | Buy |
100,515
+11,784
| +13% | +$1.04M | 0.14% | 101 |
|
|
2018
Q3 | $8.39M | Sell |
88,731
-5,572
| -6% | -$528K | 0.11% | 121 |
|
|
2018
Q2 | $8.85M | Buy |
94,303
+1,549
| +2% | +$151K | 0.12% | 110 |
|
|
2018
Q1 | $8.78M | Sell |
92,754
-33,543
| -27% | -$3.68M | 0.12% | 115 |
|
|
2017
Q4 | $12.2M | Buy |
126,297
+1,825
| +1% | +$172K | 0.16% | 93 |
|
|
2017
Q3 | $11.1M | Buy |
124,472
+1,309
| +1% | +$99.6K | 0.16% | 93 |
|
|
2017
Q2 | $8.93M | Buy |
123,163
+4,299
| +4% | +$289K | 0.15% | 100 |
|
|
2017
Q1 | $7.76M | Buy |
118,864
+11,576
| +11% | +$728K | 0.13% | 115 |
|
|
2016
Q4 | $6.73M | Buy |
107,288
+7,062
| +7% | +$431K | 0.11% | 135 |
|
|
2016
Q3 | $6.32M | Buy |
100,226
+6,551
| +7% | +$424K | 0.12% | 132 |
|
|
2016
Q2 | $5.81M | Buy |
93,675
+18,538
| +25% | +$1.13M | 0.12% | 128 |
|
|
2016
Q1 | $4.29M | Sell |
75,137
-63,395
| -46% | -$3.53M | 0.09% | 133 |
|
|
2015
Q4 | $8.21M | Hold |
138,532
| – | – | 0.19% | 97 |
|
|
2015
Q3 | $7.55M | Buy |
138,532
+19,344
| +16% | +$1.26M | 0.17% | 96 |
|
|
2015
Q2 | $7.97M | Sell |
119,188
-6,647
| -5% | -$434K | 0.16% | 111 |
|
|
2015
Q1 | $7.37M | Buy |
125,835
+56,176
| +81% | +$3.39M | 0.19% | 90 |
|
|
2014
Q4 | $4.55M | Buy |
69,659
+38,004
| +120% | +$2.4M | 0.12% | 122 |
|
|
2014
Q3 | $1.83M | Sell |
31,655
-1,218
| -4% | -$67.6K | 0.04% | 238 |
|
|
2014
Q2 | $1.86M | Sell |
32,873
-10,781
| -25% | -$566K | 0.04% | 229 |
|
|
2014
Q1 | $2.24M | Sell |
43,654
-1,737
| -4% | -$87.8K | 0.05% | 186 |
|
|
2013
Q4 | $2.4M | Buy |
45,391
+9,906
| +28% | +$487K | 0.06% | 179 |
|
|
2013
Q3 | $1.59M | Buy |
35,485
+1,543
| +5% | +$68.4K | 0.04% | 202 |
|
|
2013
Q2 | $1.4M | Buy |
+33,942
| New | +$1.48M | 0.05% | 186 |
|
Other funds holding ABBV
VCM
VPM
Scotia Capital's ABBV Position: Q1 2026 in Review
Scotia Capital reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $1.01M and leaving 183,643 shares worth $39.9M. The position accounts for 0.16% of the portfolio, ranked #89.
Scotia Capital first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $43M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Scotia Capital held 183,643 shares of AbbVie worth $39.9M as of Q1 2026.
- Scotia Capital sold 4,561 AbbVie shares in Q1 2026, an estimated $1.01M.
- AbbVie made up 0.16% of Scotia Capital's portfolio in Q1 2026, its #89 holding.
- Scotia Capital first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Scotia Capital's AbbVie position peaked at $43M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.